查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942564

2026年全球循環性腫瘤細胞市場報告

Circulating Tumor Cells Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，循環性腫瘤細胞市場規模快速成長，預計將從2025年的132.7億美元成長到2026年的149.9億美元，複合年成長率達13.0%。過去幾年的成長可歸因於癌症發生率的上升、腫瘤學研究計畫的擴展、血液診斷技術的日益普及、微創檢測方法的廣泛應用以及先進實驗室技術的普及。

預計未來幾年循環性腫瘤細胞）市場規模將快速成長，2030年將達到238.8億美元，複合年成長率（CAGR）為12.3%。預測期內的成長將受到以下因素的驅動：個人化癌症診斷的日益普及、癌症生物標記研究投資的增加、自動化細胞捕獲技術的廣泛應用、對早期癌症檢測工具的需求不斷成長以及人工智慧在癌症診斷中日益增強的整合。預測期內的關鍵趨勢包括：液態生物檢體技術的日益廣泛應用、微流體CTC分離裝置的日益普及、自動化CTC分析系統的日益整合、腫瘤學研究應用的不斷擴展以及對早期癌症檢測的日益重視。

預計未來幾年，癌症發生率的不斷上升將推動循環性腫瘤細胞市場的擴張。癌症是一種體內某些細胞不受控制地生長並轉移到其他器官和組織的疾病。循環性腫瘤細胞可用於癌症的早期檢測和診斷，隨著癌症發生率的持續上升，對這些技術的需求也隨之增加。例如，根據世界衛生組織（世衛組織）2024年2月發布的數據，預計到2050年，新增癌症病例將超過3,500萬例，比2022年估計的2,000萬例增加77%。世衛組織是一個專注於全球衛生政策和公共衛生舉措的瑞士國際組織。因此，日益加重的癌症負擔正在顯著推動循環性腫瘤細胞市場的成長。

為了滿足日益成長的對精準、非侵入性癌症診斷和更完善的個人化治療監測的需求，循環性腫瘤細胞(CTC) 領域的主要企業正致力於開發先進的解決方案，例如生物標記特異性CTC 檢測。這些生物標記特異性檢測能夠基於特定蛋白的表達來檢測和詳細表徵循環性腫瘤細胞，從而提供比傳統 CTC 計數技術（僅提供細胞總數）更豐富的表現型資訊。例如，2023 年 7 月，總部位於義大利的診斷公司 Menarini Silicon Biosystems 在北美和歐洲推出了包含 DLL3 生物標記的 CELLSEARCH CTC 檢測，目前僅供研究使用。此檢測基於已獲 FDA 批准的 CELLSEARCH 平台，旨在識別表達 DLL3 的循環性腫瘤細胞。 DLL3 是一種在侵襲性小細胞肺癌和神經內分泌腫瘤中過度表現的蛋白質。透過靶向 DLL3，該檢測方法支持對預後不良相關的循環腫瘤細胞 (CTC) 進行表現型分析，並促進以標靶治療開發為重點的生物製藥研究。這項進展使研究人員能夠以非侵入性方式探索腫瘤異質性、追蹤疾病進展並評估對精準療法的反應。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球循環性腫瘤細胞市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧與自主智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 擴大液態生物檢體技術的應用
    • 微流體腫瘤細胞分離裝置的應用日益廣泛
    • 自動化CTC分析系統整合方面的進展
    • 拓展腫瘤學研究應用
    • 人們越來越重視癌症早期檢測

第5章 終端用戶產業市場分析

  • 醫院和癌症中心
  • 診斷檢查室
  • 製藥和生物技術公司
  • 學術研究機構
  • CRO（受託研究機構）

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球循環性腫瘤細胞市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球循環性腫瘤細胞市場規模、對比及成長率分析
  • 全球循環性腫瘤細胞市場表現：規模與成長，2020-2025年
  • 全球循環性腫瘤細胞市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品
  • 試劑盒及試劑、採血管、裝置或系統
  • 透過技術
  • CTC富集、CTC檢測、CTC分析
  • 透過使用
  • 臨床或液態生物檢體，檢查
  • 按類型細分：試劑盒和試劑
  • 細胞富集試劑盒、檢測試劑盒、核酸分離試劑盒
  • 按類型細分：採血管
  • 標準採血管，特殊採血管
  • 按類型細分：設備或系統
  • 微流體裝置、自動化細胞捕捉系統、影像系統

第10章 區域與國家分析

  • 全球循環性腫瘤細胞市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球循環性腫瘤細胞市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 循環性腫瘤細胞市場：競爭格局及市場佔有率（2024年）
  • 循環性腫瘤細胞市場：公司估值矩陣
  • 循環性腫瘤細胞市場：公司概況
    • BIOCEPT Inc.
    • Creativ MicroTech Inc.
    • Fluxion Biosciences Inc.
    • Ikonisys Inc.
    • ScreenCell SAS

第37章：其他領先和創新企業

  • Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems SpA, Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年循環性腫瘤細胞市場：提供新機會的國家
  • 2030年循環性腫瘤細胞市場：充滿新機會的細分市場
  • 2030年循環性腫瘤細胞市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MCTCU01_G26Q1

Circulating tumor cells (CTCs) represent solid tumor-derived cells that have detached from the primary tumor and entered the bloodstream, providing valuable diagnostic and prognostic information for cancer.

The primary products related to circulating tumor cells encompass kits and reagents, along with blood collection tubes and devices or systems. Kits and reagents constitute a comprehensive set of consumables comprising elements such as a blood specimen separator, proprietary microfluidic capture chip, CTC enrichment, and immunostaining reagents. These products are utilized for collecting various specimens from the human body, including blood, bone marrow, and other bodily fluids. They leverage different technologies such as CTC enrichment, detection, and analysis, facilitating applications in clinical or liquid biopsy procedures, as well as in research endeavors.

Tariffs are impacting the circulating tumor cells market by increasing costs of imported microfluidic devices, imaging systems, reagents, and automated cell capture equipment. Oncology research centers and diagnostic laboratories in North America and Europe are most affected due to reliance on specialized imported instruments, while Asia-Pacific faces higher manufacturing input costs. These tariffs are raising test costs and slowing technology adoption. However, they are also encouraging domestic device development, localized reagent production, and regional innovation in liquid biopsy platforms.

The circulating tumor cells market research report is one of a series of new reports from The Business Research Company that provides circulating tumor cells market statistics, including circulating tumor cells industry global market size, regional shares, competitors with a circulating tumor cells market share, detailed circulating tumor cells market segments, market trends and opportunities, and any further data you may need to thrive in the circulating tumor cells industry. This circulating tumor cells market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The circulating tumor cells market size has grown rapidly in recent years. It will grow from $13.27 billion in 2025 to $14.99 billion in 2026 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to increasing cancer incidence rates, expansion of oncology research programs, growing use of blood-based diagnostics, rising adoption of minimally invasive testing methods, availability of advanced laboratory technologies.

The circulating tumor cells market size is expected to see rapid growth in the next few years. It will grow to $23.88 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing adoption of personalized oncology diagnostics, rising investments in cancer biomarker research, expansion of automated cell capture technologies, growing demand for early-stage cancer detection tools, increasing integration of ai in oncology diagnostics. Major trends in the forecast period include increasing use of liquid biopsy techniques, rising adoption of microfluidic ctc isolation devices, growing integration of automated ctc analysis systems, expansion of oncology research applications, enhanced focus on early cancer detection.

The increasing prevalence of cancer is anticipated to drive the expansion of the circulating tumor cells market in the coming years. Cancer is a condition in which certain cells in the body multiply uncontrollably and spread to other organs or tissues. Circulating tumor cells are utilized for the early identification and diagnosis of cancer, and as cancer incidence continues to rise, the demand for these technologies is growing accordingly. For example, in February 2024, according to the World Health Organization, a Switzerland-based international body focused on global health policy and public health initiatives, more than 35 million new cancer cases are projected by 2050, representing a 77% increase compared with the estimated 20 million cases reported in 2022. As a result, the rising burden of cancer is contributing significantly to the growth of the circulating tumor cells market.

Leading companies operating in the circulating tumor cells (CTC) space are increasingly concentrating on the development of advanced solutions, such as biomarker-specific CTC assays, to address the growing need for accurate, non-invasive cancer diagnostics and improved personalized treatment monitoring. These biomarker-specific assays allow for the detection and detailed characterization of circulating tumor cells based on particular protein expressions, providing richer phenotypic insights than conventional CTC enumeration techniques that largely deliver only total cell counts. For instance, in July 2023, Menarini Silicon Biosystems S.p.A., an Italy-based diagnostics firm, launched the CELLSEARCH CTC test incorporating the DLL3 biomarker as a Research Use Only service across North America and Europe. Built on the FDA-cleared CELLSEARCH platform, the assay is designed to identify circulating tumor cells expressing DLL3, a protein commonly overexpressed in aggressive small-cell lung cancer and neuroendocrine tumors. By targeting DLL3, the test supports phenotypic profiling of CTCs linked to poor prognosis, thereby aiding biopharmaceutical research focused on targeted therapy development. This advancement offers researchers a non-invasive approach to investigate tumor heterogeneity, track disease progression, and assess responses to precision treatments.

In August 2023, Cell Microsystems, a US-based biotechnology company, acquired Fluxion Biosciences for an undisclosed amount. This acquisition is intended to strengthen Cell Microsystems' capabilities in cell analysis and offer advanced solutions for both research and clinical applications. Fluxion Biosciences, also based in the US, specializes in technologies for isolating and analyzing circulating tumor cells (CTCs).

Major companies operating in the circulating tumor cells market are BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., ScreenCell SAS, Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation, Qiagen N.V., STEMCELL Technologies Inc., Sysmex Corporation, Miltenyi Biotec GmbH, Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Agilent Technologies Inc.

North America was the largest region in the circulating tumor cells market in 2025. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the circulating tumor cells market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The circulating tumor cells market consists of sales of clinical samples, KRT7, PSMA positive cells, and TTF-1 positive. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Circulating Tumor Cells Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses circulating tumor cells market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for circulating tumor cells ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The circulating tumor cells market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Blood Collection Tubes; Devices Or Systems
  • 2) By Technology: CTC Enrichment; CTC Detection; CTC Analysis
  • 3) By Application: Clinical Or Liquid Biopsy; Research
  • Subsegments:
  • 1) By Kits And Reagents: Cell Enrichment Kits; Detection Kits; Nucleic Acid Isolation Kits
  • 2) By Blood Collection Tubes: Standard Blood Collection Tubes; Specialized Blood Collection Tubes
  • 3) By Devices Or Systems: Microfluidic Devices; Automated Cell Capture Systems; Imaging Systems
  • Companies Mentioned: BIOCEPT Inc.; Creativ MicroTech Inc.; Fluxion Biosciences Inc.; Ikonisys Inc.; ScreenCell SAS; Aviva Biosciences Corporation; LungLife AI Inc.; Menarini Silicon Biosystems S.p.A.; Canopus Bioscience Ltd.; IVDiagnostics Inc.; BioFluidica Inc.; Biolidics Limited; Rarecells Diagnostics SAS; Cynvenio Biosystems Inc.; ApoCell Inc.; Clearbridge BioMedics Pte. Ltd.; Celsee Inc.; RareCyte Inc.; On-chip Biotechnologies Co. Ltd.; Bio-Techne Corporation; Qiagen N.V.; STEMCELL Technologies Inc.; Sysmex Corporation; Miltenyi Biotec GmbH; Thermo Fisher Scientific Inc.; Greiner Bio-One International GmbH; Agilent Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Circulating Tumor Cells Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Circulating Tumor Cells Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Circulating Tumor Cells Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Circulating Tumor Cells Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Artificial Intelligence And Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.4 Industry 4.0 And Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of Liquid Biopsy Techniques
    • 4.2.2 Rising Adoption Of Microfluidic Ctc Isolation Devices
    • 4.2.3 Growing Integration Of Automated Ctc Analysis Systems
    • 4.2.4 Expansion Of Oncology Research Applications
    • 4.2.5 Enhanced Focus On Early Cancer Detection

5. Circulating Tumor Cells Market Analysis Of End Use Industries

  • 5.1 Hospitals And Cancer Centers
  • 5.2 Diagnostic Laboratories
  • 5.3 Pharmaceutical And Biotechnology Companies
  • 5.4 Academic And Research Institutes
  • 5.5 Contract Research Organizations

6. Circulating Tumor Cells Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Circulating Tumor Cells Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Circulating Tumor Cells PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Circulating Tumor Cells Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Circulating Tumor Cells Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Circulating Tumor Cells Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Circulating Tumor Cells Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Circulating Tumor Cells Market Segmentation

  • 9.1. Global Circulating Tumor Cells Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits And Reagents, Blood Collection Tubes, Devices Or Systems
  • 9.2. Global Circulating Tumor Cells Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • CTC Enrichment, CTC Detection, CTC Analysis
  • 9.3. Global Circulating Tumor Cells Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Or Liquid Biopsy, Research
  • 9.4. Global Circulating Tumor Cells Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
  • 9.5. Global Circulating Tumor Cells Market, Sub-Segmentation Of Blood Collection Tubes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Blood Collection Tubes, Specialized Blood Collection Tubes
  • 9.6. Global Circulating Tumor Cells Market, Sub-Segmentation Of Devices Or Systems, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

10. Circulating Tumor Cells Market Regional And Country Analysis

  • 10.1. Global Circulating Tumor Cells Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Circulating Tumor Cells Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Circulating Tumor Cells Market

  • 11.1. Asia-Pacific Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Circulating Tumor Cells Market

  • 12.1. China Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Circulating Tumor Cells Market

  • 13.1. India Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Circulating Tumor Cells Market

  • 14.1. Japan Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Circulating Tumor Cells Market

  • 15.1. Australia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Circulating Tumor Cells Market

  • 16.1. Indonesia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Circulating Tumor Cells Market

  • 17.1. South Korea Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Circulating Tumor Cells Market

  • 18.1. Taiwan Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Circulating Tumor Cells Market

  • 19.1. South East Asia Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Circulating Tumor Cells Market

  • 20.1. Western Europe Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Circulating Tumor Cells Market

  • 21.1. UK Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Circulating Tumor Cells Market

  • 22.1. Germany Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Circulating Tumor Cells Market

  • 23.1. France Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Circulating Tumor Cells Market

  • 24.1. Italy Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Circulating Tumor Cells Market

  • 25.1. Spain Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Circulating Tumor Cells Market

  • 26.1. Eastern Europe Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Circulating Tumor Cells Market

  • 27.1. Russia Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Circulating Tumor Cells Market

  • 28.1. North America Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Circulating Tumor Cells Market

  • 29.1. USA Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Circulating Tumor Cells Market

  • 30.1. Canada Circulating Tumor Cells Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Circulating Tumor Cells Market

  • 31.1. South America Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Circulating Tumor Cells Market

  • 32.1. Brazil Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Circulating Tumor Cells Market

  • 33.1. Middle East Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Circulating Tumor Cells Market

  • 34.1. Africa Circulating Tumor Cells Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Circulating Tumor Cells Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Circulating Tumor Cells Market Regulatory and Investment Landscape

36. Circulating Tumor Cells Market Competitive Landscape And Company Profiles

  • 36.1. Circulating Tumor Cells Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Circulating Tumor Cells Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Circulating Tumor Cells Market Company Profiles
    • 36.3.1. BIOCEPT Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Creativ MicroTech Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Fluxion Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Ikonisys Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. ScreenCell SAS Overview, Products and Services, Strategy and Financial Analysis

37. Circulating Tumor Cells Market Other Major And Innovative Companies

  • Aviva Biosciences Corporation, LungLife AI Inc., Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd., Bio-Techne Corporation

38. Global Circulating Tumor Cells Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Circulating Tumor Cells Market

40. Circulating Tumor Cells Market High Potential Countries, Segments and Strategies

  • 40.1 Circulating Tumor Cells Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Circulating Tumor Cells Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Circulating Tumor Cells Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer